default author photo

Zhu Jun

Peking University - Key Laboratory of Carcinogenesis and Translational Research

No. 38 Xueyuan Road

Haidian District

Beijing, Beijing 100871

China

SCHOLARLY PAPERS

6

DOWNLOADS

502

TOTAL CITATIONS

2

Scholarly Papers (6)

Steadily Decline of HBV DNA Load Under NAs in Lymphoma Patients and Higher Level of qAnti-HBc Predict HBV Reactivation

Number of pages: 24 Posted: 27 Apr 2023
Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Infectious Disease, Peking University - Department of Infectious Disease, Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Peking University - Department of Infectious Disease
Downloads 62 (957,329)

Abstract:

Loading...

lymphoma, diffuse large B-cell, hepatitis B virus infection, HBV reactivation, qAnti-HBc

Steadily Decline of HBV DNA Load Under NAs in Lymphoma Patients and Higher Level of qAnti-HBc Predict HBV Reactivation

Number of pages: 23 Posted: 03 Mar 2023
Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Infectious Disease, Peking University - Department of Infectious Disease, Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Infectious Disease, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Peking University - Department of Infectious Disease
Downloads 54 (1,038,620)

Abstract:

Loading...

lymphoma, diffuse large B-cell, hepatitis B virus infection, HBV reactivation, qAnti-HBc

2.

Ibrutinib Combined With Low-Dose HDAC Inhibitor Chidamide Synergistically Enhances the Anti-Tumor Effect in B-Cell Lymphoma

Number of pages: 20 Posted: 31 Jan 2022
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads 99 (704,534)

Abstract:

Loading...

BTK inhibitor, HDAC inhibitor, B-cell lymphoma, Drug combination, Tumor microenvironment

3.

Mortality Rate of Lymphoma in China, 2013-2020

Number of pages: 24 Posted: 08 Nov 2021
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Harbin Institute of Hematology & Oncology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Independent and Independent
Downloads 94 (720,278)

Abstract:

Loading...

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Epidemiology, Mortality

4.

Burden of Lymphoma in China, 1990−2019: An Analysis of Global Burden of Diseases, Injuries, and Risk Factors Study 2019

Number of pages: 26 Posted: 30 Jul 2021
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Chinese Center for Disease Control and Prevention (China CDC), Peking University - Peking University Cancer Hospital & Institute, Peking University, Peking University, Beijing Institute of Survey and Mapping, Harbin Institute of Hematology & Oncology, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Harbin Institute of Hematology & Oncology and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads 74 (844,901)
Citation 2

Abstract:

Loading...

Lymphoma; Hodgkin Disease; Lymphoma, Non-Hodgkin; Epidemiology; Incidence; Mortality

5.

Evidence of Cure for Extranodal Nasal-Type NK/T-Cell Lymphoma with Modern Treatment: An Analysis of the CLCG Database

Number of pages: 34 Posted: 31 May 2022
Chinese Academy of Medical Sciences - National Clinical Research Center for Cancer, Huazhong University of Science and Technology - Union Hospital, First Medical Center of Chinese PLA General Hospital, Government of the People's Republic of China - Beijing Hospital, Anhui Provincial Hospital, Fujian Medical University - Department of Radiation Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Hebei Medical University - Fourth Hospital, Nanchang University - Second Affiliated Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Shanxi Cancer Hospital, Fujian Provincial Cancer Hospital, Guizhou Medical University (Guiyang Medical University) - Affiliated Hospital, Central South University - Hunan Cancer Hospital, Government of the People's Republic of China - Xijing Hospital, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Government of the People's Republic of China - Fifth Medical Center of Chinese PLA General Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Chongqing University Cancer Hospital, Qinghai University - Qinghai University Affiliated Hospital, Qinghai University - Qinghai University Affiliated Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Soochow University - Department of Radiation Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology
Downloads 65 (924,743)

Abstract:

Loading...

Extranodal nasal-type NK/T-cell lymphoma, Cure fraction, Relative survival, Prognosis, Non-anthracycline-based chemotherapy, Radiotherapy

6.

Comprehensive Analysis of Peripheral T-Cell and Natural Killer/T-Cell Lymphoma in Asian Patients: A Multinational, Multicenter, Prospective Registry Study in Asia

Number of pages: 45 Posted: 17 Dec 2020
Sungkyunkwan University - Samsung Medical Center, Peking University - Peking University Cancer Hospital & Institute, Sungkyunkwan University - Division of Hematology-Oncology, University of Ulsan - Department of Oncology, National Cheng Kung University - Division of Hematology and Oncology, Seoul National University - Department of Internal Medicine, Anam Hospital Korea University Medical Center - Department of Internal Medicine, Division of Hematology-Oncology, Kosin University Gospel Hospital, Department of Internal Medicine, Chungnam National University College of Medicine, Chinese Academy of Medical Sciences - National Cancer Center, Department of Haematology-Oncology, National University Health System, University of Indonesia (UI), Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Keimyung University - Dongsan Medical Center, Department of Hematology-Oncology, Konkuk University Medical Center, Subang Jaya Medical Center, Division of Hemato-Oncology, Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Fudan University Shanghai Cancer Center, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Korea Institute of Radiological and Medical Sciences, Department of Internal Medicine, Chungnam National University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Raffles Cancer Centre, Division of Hematology–Oncology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University, Department of Hematology and Medical Oncology, College of Medicine, Kyung Hee University, Division of Hematology–Oncology, Ewha Womans University Mokdong Hospital, Ewha Womans University, Dong-A University, School of Medicine, Dong-A University Hospital, Department of Internal Medicine, Department of Internal Medicine, Wonkwang University School of Medicine, Chungnam National University, Inje University - Department of Medicine, Department of Internal Medicine, Soonchunhyang University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Sungkyunkwan University - Samsung Medical Center, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 54 (1,020,567)

Abstract:

Loading...

Lymphoma, T-Cell, Peripheral; Lymphoma, Extranodal NK-T-Cell; Incidence; Therapeutics; Survival; Prognosis